Fairchem Organics Ltd · NSE:FAIRCHEMOR
Fairchem Organics — Q2 FY23 Earnings Presentation
16 slides from Fairchem Organics's earnings presentation, Nov 10, 2022
Slide 1: Exchange filing cover letter: Q2 Earnings Presentation
FAIRCHEM ORGANICS LIMITED Regd. Office 253/P & 312, Village Chekhala, Sanand Kadi Highway, - & Works : Taluka SANAND, District: Ahmedabad -382 115, GUJARAT, INDIA. Phone (Board Nos.) : (02717) 687900,687901, ÷91 90163 24095 FAIRCHEM E-mail: cs@fairchem.in A FAIRFAX COMPANY CIN: L24200GJ2019PLC129759
Slide 2: Earnings Presentation Q2/H1-FY23
Earnings Presentation Q2/H1-FY23
Slide 3: Company at a Glance
Company at a Glance Well entrenched Forward integration to make Customer value added products such as Relationships in Promoted by Fairfax Tocopherols 50%, Sterols 90% Long lasting Pan India high growth India Holdings and from current intermediate Raw Material sourcing Nutraceuticals stream, Methyl
Slide 4: Company Overview
Company Overview • Fairchem Organics Ltd. (Fairchem) is engaged in the business of manufacturing of Oleo Chemicals and Nutraceuticals, since the last 25 years. Revenue & EBITDA Margin (In Mn) • It has a state -of-the-art Manufacturing unit which was set up in 1995 and has over the years 6,432 gone t
Slide 5: Fairchem's Competitive Advantage
Fairchem’s Competitive Advantage Major Player in the Indian Oleo Chemical Market Using Renewable Resources • Processing waste from edible oil refining process to produce high value oleo chemicals giving it price advantage • Enjoy Leadership Position in the industry due to barriers to entry • Focus o
Slide 6: ESG Initiatives
ESG Initiatives ENVIRONMENT SOCIAL GOVERNANCE CSR Activites Effluent Method of Disposal • Dr. Jivraj Mehta Smarak Health Foundation • Always be adequately capitalized - Purchase of Ventilator Machine Zero Liquid Discharge by Multi • Not overleverage the balance sheet Water Effect Evaporator and Agit
Slide 7: Key Financial Highlights
g FAIRCHEM Key Financial Highlights
Slide 8: Q2/H1-FY23 Financial & Operational Highlights
Q2/H1-FY23 Financial & Operational Highlights Q2-FY23 Financial Performance • Decline in Revenues was driven by lower per unit realisations vis-à-vis the previous quarter. INR 1,685 Mn INR 93 Mn 5.52% Revenue from • The adverse impact on profitability was primarily due to reduction in EBITDA Operati
Slide 9: Quarterly Financial Performance
Quarterly Financial Performance PARTICULARS (INR Mn) Q2-FY23 Q2-FY22 Y-O-Y Q1-FY23 Q-O-Q Revenue from Operations 1,685 1,680 0.3% 2,251 (25.1)% Total Expenses 1,592 1,362 16.9% 1,851 (14.0)% EBITDA 93 318 (70.8)% 400 (76.8)% EBITDA Margins (%) 5.52% 18.93% NA 17.77% NA Other Income - - - 3 NA Deprec
Slide 10: YTD Financial Performance
YTD Financial Performance PARTICULARS (INR Mn) H1-FY23 H1-FY22 Y-O-Y Revenue from Operations 3,937 3,071 28.2% Total Expenses 3,443 2,423 42.1% EBITDA 494 648 (23.8)% EBITDA Margins (%) 12.55% 21.10% (855) Bps Other Income 2 3 (33.3)% Depreciation 39 35 11.4% Finance Cost 40 37 8.1% PBT 417 579 (28.
Slide 11: Historical Income Statement
Historical Income Statement PARTICULARS (INR Mn) FY20 FY21 FY22 H1-FY23 Revenue from Operations 3,065 3,966 6,432 3,937 Total Expenses 2,581 3,279 5,383 3,443 EBITDA 484 687 1,049 494 EBITDA Margins (%) 15.79% 17.32% 16.31% 12.55% Other Income 66 3 3 2 Depreciation 60 66 71 39 Finance Cost 66 68 69
Slide 12: Historical Balance Sheet
Historical Balance Sheet ASSETS FY21 FY22 H1-FY23 EQUITY AND LIABILITIES FY21 FY22 H1-FY23 Non-Current Assets EQUITY Property, Plant and Equipment 1,220 1,363 1,468 Equity Share Capital 130 130 130 Instruments entirely equity in nature Capital work-in-progress 295 420 358 Other Equity 1,557 2,191 2,
Slide 13: Historical Cash Flow Statement
Historical Cash Flow Statement PARTICULARS (INR Mn) FY21 FY22 H1-FY23 Cash and Cash Equivalents at Beginning of the year 0.3 0.3 - Cash Flow From Operating Activities 394 405 704 Cash Flow from Investing Activities (228) (342) (76) Cash Flow From Financing Activities (166) (63) (628) Net Inc./(Dec.)
Slide 14: Key Financial Highlights
Key Financial Highlights Revenue (In Mn) EBITDA (In Mn) & EBITDA Margin (%) PAT (In Mn) & PAT Margin (%) 5 Year CAGR - 26% 5 Year CAGR - 35% 5 Year CAGR - 49% 6,432 1,049 679 3,966 3,937 687 425 3,065 494 347 310 484 2,428 2,499 361 338 194 215 17.32% 16.31% 11.32% 10.72% 10.56% 13.92% 14.44% 15.79%
Slide 15: Capital Market Data
Capital Market Data Stock Market Performance (as on 30th Sept, 2022) Dividend Percentage 20% 130.00% 10% 0% -10% -20% 35.00% -30% 25.00% 15.00% 15.00% -40% Oct-21 Nov-21 Dec-21 Jan-22 Feb-22 Mar-22 Apr-22 May-22 Jun-22 Jul-22 Aug-22 Sep-22 Fai rchem Sensex FY18 FY19 FY20 FY21 FY22 Price Data as at 3
Slide 16: Disclaimer
Disclaimer Fairchem Organics Limited Disclaimer: The information contained in this presentation is only current as of its date. All actions and statements made herein or otherwise shall be subject to the applicable laws and regulations as amended from time to time. There is no representation that al